Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Liver-directed therapy
5 evidence topics · 5 sources
Embolization and cytoreduction for uncontrolled functioning syndromes: ENETS 2023 guidance
Liver-directed options for metastatic insulinoma
“Also, liver metastases can be resected, or treated by trans-arterial bland or chemo-embolization, radioembolization, radiofrequency ablation, microwave and cryoablation, high-intensity focused ultrasound, laser, brachytherapy, and irreversible electroporation depending on the local availability” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, most aggressive malignant metastatic insulinomas cannot be cured by surgery or ablation procedures alone and require supportive measures, medical antihormonal, and antitumor treatment” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Bland hepatic artery embolization for refractory hypoglycemia from insulinoma liver metastases
“Twenty patients (10 women, 10 men; mean age, 56 years; range, 18-84 years) were identified who individually underwent 1 (n = 7), 2 (n = 5), 3 (n = 5), 4 (n = 2), or 5 (n = 1) HAEs, for an overall total of 45 HAEs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Postprocedural hypoglycemic symptom relief after the first HAE was reported in 100% (n = 20) of patients before discharge or at follow-up.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Post-HAE hypoglycemia recurrence occurred in 60% (n = 12) of patients with a median time to first hypoglycemia recurrence of 2 months (mean, 14 months; range, 0.2-60 months).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“After the first HAE, median HFS was 14.5 months, and median OS was 16 months.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“IV fluids containing dextrose given preprocedurally in 85% (n = 17) of patients were stopped either immediately postprocedure, on resumption of oral intake, or before discharge, in all patients after the first HAE.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“One patient experienced labile postprocedure blood glucose levels requiring intensive care unit admission for intravenous dextrose.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Chemoembolization and radioembolization for intractable hypoglycemia in metastatic insulinoma
“Seven patients were identified (4 male patients).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Technical success rate was 97% (32/33 procedures) with an initial clinical success rate of 100%, defined as absence of recurrent symptomatic hypoglycemia within 1 month after first cycle of LDT and overall clinical success rate of 85%.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Random daytime glucose levels increased from 75.0 (SD, 26) mg/dL to 152.8 (SD, 52.4) mg/dL after LDT.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The mean time to recurrence of intractable hypoglycemia was 21 (SD, 9) months.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote